home / stock / insm / insm news


INSM News and Press, Insmed Inc. From 01/05/24

Stock Information

Company Name: Insmed Inc.
Stock Symbol: INSM
Market: NASDAQ
Website: insmed.com

Menu

INSM INSM Quote INSM Short INSM News INSM Articles INSM Message Board
Get INSM Alerts

News, Short Squeeze, Breakout and More Instantly...

INSM - Insmed Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference

Insmed Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference PR Newswire —ARIKAYCE ® (amikacin liposome inhalation suspension) Delivers Full-Year 2023 Revenues Exceeding the Upper End of Guidance Range with Unaudited Global Net Product Sales o...

INSM - Insmed To Present at the 42nd Annual J.P. Morgan Healthcare Conference

Insmed To Present at the 42nd Annual J.P. Morgan Healthcare Conference PR Newswire BRIDGEWATER, N.J. , Jan. 2, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious...

INSM - Insmed Incorporated ($INSM) Trading Signals

2023-12-14 17:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

INSM - Insmed To Present at the Nasdaq 49th Investor Conference

Insmed To Present at the Nasdaq 49th Investor Conference PR Newswire BRIDGEWATER, N.J. , Nov. 29, 2023 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare dis...

INSM - JP Morgan bullish on six Big Biotechs, rates nine others neutral or lower

2023-11-25 16:32:53 ET More on BioCryst Pharmaceuticals, Crinetics Pharmaceuticals, etc. Mirum Pharmaceuticals, Inc. (MIRM) Q3 2023 Earnings Call Transcript BioCryst Pharmaceuticals, Inc. (BCRX) Q3 2023 Earnings Call Transcript Immunocore: First Half Of 2024 IMC-F106...

INSM - Insmed To Present at Two November Conferences

Insmed To Present at Two November Conferences PR Newswire BRIDGEWATER, N.J. , Nov. 8, 2023 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today ...

INSM - Insmed Holds Second Annual Global Day of Good to Benefit Communities Across the Globe

Insmed Holds Second Annual Global Day of Good to Benefit Communities Across the Globe PR Newswire — Company-wide day of service brings more than 700 employees together to volunteer in 25 locations throughout the U.S., Europe , and Japan — BRIDGE...

INSM - Insmed Ranks No. 1 on Science's 2023 Top Biopharma Employers List

Insmed Ranks No. 1 on Science's 2023 Top Biopharma Employers List PR Newswire -- Insmed Leads Science Top Employers List for Third Consecutive Year -- BRIDGEWATER, N.J. , Oct. 26, 2023 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global bioph...

INSM - Insmed, Inc. (INSM) Q3 2023 Earnings Call Transcript

2023-10-26 15:02:10 ET Insmed, Inc. (INSM) Q3 2023 Earnings Conference Call October 26, 2023, 08:30 ET Company Participants Bryan Dunn - IR William Lewis - President, CEO & Chairman Sara Bonstein - CFO Conference Call Participants Andrea Tan - Gol...

INSM - Insmed Non-GAAP EPS of -$1.11 in-line, revenue of $79.07M misses by $0.25M

2023-10-26 07:33:19 ET More on Insmed Insmed's Arikayce: A High Flyer With A Heavy Load Insmed Incorporated (INSM) Q2 2023 Earnings Call Transcript Insmed gains as antibacterial agent hits main goal in Phase 3 trial Seeking Alpha’s Quant Rating on Insm...

Previous 10 Next 10